Abbisko Therapeutics to Present Updated Results from the Phase 2 Study of Irpagratinib in Combination with Atezolizumab for the Treatment of Advanced Hepatocellular Carcinoma at the 2025 ESMO GI Congr

5 hours ago 1
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Abbisko Therapeutics to Present Updated Results from the Phase 2 Study of Irpagratinib in Combination with Atezolizumab for the Treatment of Advanced Hepatocellular Carcinoma at the 2025 ESMO GI Congr

Related

China says fentanyl issue is responsibility of the United States

China says fentanyl issue is responsibility of the United St...

2 hours ago 0
Goldman Sachs cuts US recession odds to 35% from 45% on trade truce optimism

Goldman Sachs cuts US recession odds to 35% from 45% on trad...

2 hours ago 0
Australia stocks higher at close of trade; S&P/ASX 200 up 0.43%

Australia stocks higher at close of trade; S&P/ASX 200 up 0....

2 hours ago 0
RIGHT SIDEBAR TOP AD

Trending

1. morgan wallen
2. edc las vegas
3. dnc vice chair election
4. full moon flower moon
5. san francisco 49ers
6. xavi
7. burkina faso
8. eye drops recalled
9. olivia munn
10. kelvin harrison jr

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

1 month ago 131
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

1 month ago 104
Stanford 2025 AI Index Reveals Surge in Adoption, Investment, and Global Impact as Trust and Regulation Lag Behind

Stanford 2025 AI Index Reveals Surge in Adoption, Investment...

1 month ago 90
Bitcoin Slips With XRP, ADA as Nvidia's Massive $5.5B Charge Sours Investor Sentiment

Bitcoin Slips With XRP, ADA as Nvidia's Massive $5.5B Charge...

3 weeks ago 89
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

1 month ago 88
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved